Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine
H Chaytow, KME Faller, YT Huang… - Cell Reports Medicine, 2021 - cell.com
Spinal muscular atrophy (SMA) is a devastating childhood motor neuron disease that, in the
most severe cases and when left untreated, leads to death within the first two years of life …
most severe cases and when left untreated, leads to death within the first two years of life …
Inhibition of RNA-binding proteins with small molecules
P Wu - Nature Reviews Chemistry, 2020 - nature.com
Protein–RNA interactions have crucial roles in various cellular activities, which, when
dysregulated, can lead to a range of human diseases. The identification of small molecules …
dysregulated, can lead to a range of human diseases. The identification of small molecules …
[HTML][HTML] Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls
Background Type 1 spinal muscular atrophy (SMA) is a progressive neuromuscular disease
characterized by an onset at 6 months of age or younger, an inability to sit without support …
characterized by an onset at 6 months of age or younger, an inability to sit without support …
New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?
TH Chen - International journal of molecular sciences, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is a congenital neuromuscular disorder characterized by
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …
Spinal muscular atrophy
S Nicolau, MA Waldrop, AM Connolly… - Seminars in pediatric …, 2021 - Elsevier
Spinal muscular atrophy is one of the most common neuromuscular disorders of childhood
and has high morbidity and mortality. Three different disease-modifying treatments were …
and has high morbidity and mortality. Three different disease-modifying treatments were …
Overturning the paradigm of spinal muscular atrophy as just a motor neuron disease
Spinal muscular atrophy is typically characterized as a motor neuron disease. Untreated
patients with the most severe form, spinal muscular atrophy type 1, die early with infantile …
patients with the most severe form, spinal muscular atrophy type 1, die early with infantile …
New approaches to target RNA binding proteins
AR Julio, KM Backus - Current opinion in chemical biology, 2021 - Elsevier
RNA binding proteins (RBPs) are a large and diverse class of proteins that regulate all
aspects of RNA biology. As RBP dysregulation has been implicated in a number of human …
aspects of RNA biology. As RBP dysregulation has been implicated in a number of human …
Therapeutic advances for Huntington's disease
Huntington's disease (HD) is a progressive neurological disease that is inherited in an
autosomal fashion. The cause of disease pathology is an expansion of cytosine-adenine …
autosomal fashion. The cause of disease pathology is an expansion of cytosine-adenine …
Alternative splicing and related RNA binding proteins in human health and disease
Y Tao, Q Zhang, H Wang, X Yang, H Mu - Signal Transduction and …, 2024 - nature.com
Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation,
engendering transcript diversity, and modifications in protein structure and functionality …
engendering transcript diversity, and modifications in protein structure and functionality …
[HTML][HTML] Targeting non-coding RNAs: Perspectives and challenges of in-silico approaches
The growing information currently available on the central role of non-coding RNAs
(ncRNAs) including microRNAs (miRNAS) and long non-coding RNAs (lncRNAs) for chronic …
(ncRNAs) including microRNAs (miRNAS) and long non-coding RNAs (lncRNAs) for chronic …